leadf
logo-loader
viewBetterLife Pharma Inc

BetterLife Pharma reveals finalized rebranding by launching its new website

BetterLife Pharma Inc. (OTCQB:BETRD) (CSE:BETR) CEO Ahmad Doroudian tells Proactive the firm has finalized its rebranding exercise for its wholly-owned subsidiary, BLife Therapeutics, which has been publicly formalized through the launching of its new website.

Doroudian says the company’s name and branding is now more consistent with its intent to become a major player within the biotechnology space. The new website, http://www.blifetherapeutics.com, provides visitors with an overview of the company’s treatment development pipeline, including information on the trial Phases for each of the treatments.

Quick facts: BetterLife Pharma Inc

Price: 0.6358 USD

OTCQB:BETRF
Market: OTCQB
Market Cap: $11.58 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of BetterLife Pharma Inc named herein, including the promotion by the Company of BetterLife Pharma Inc in any Content on the Site, the Company...

FOR OUR FULL DISCLAIMER CLICK HERE

BetterLife Pharma reveals clinical trial updates on its treatment for...

BetterLife Pharma Inc (OTCQB:BETRF) (CSE:BETR) CEO Ahmad Doroudian updates Proactive on the group's clinical trials progress, revealing it has engaged the clinical research organization Pharmaceutical Solutions Ltd to manage its study of AP-003 as a treatment for mild-to-moderate...

1 week, 2 days ago

2 min read